Search

You searched for "enucleation"

2997 results found

Esme’s Umbrella announces the world’s first Charles Bonnet Syndrome Essay Prizes

20 February 2023 |
Esme’s Umbrella (www.charlesbonnetsyndrome) has just announced the world’s first Charles Bonnet Syndrome Essay Prizes.

Hydroxychloroquine toxicity

1 August 2017 | EYE - Vitreo-Retinal, EYE - General
Being the subject of litigation is stressful and upsetting. Having to look back over your previous decisions and justify the care you delivered in good faith can be difficult. Sadly, we all live with the Sword of Damocles above us...

Cortical blindness

1 August 2014 | | EYE - Cataract, EYE - Cornea, EYE - General, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal
Cortical blindness is a rare but recognised entity. Cerebrovascular accident is a well-known risk factor. We report a case of an 84-year-old lady with bilateral cortical blindness with multiple cardiovascular risk factors. Case report An 84-year-old lady was admitted under...

Surgitrac Instruments to Exhibit at UKISCRS Cornea & Cataract Day

29 January 2026 | Company Profiles, Awards, Conferences & Anniversaries
Surgitrac Instruments is pleased to announce its participation in the United Kingdom & Ireland Society of Cataract and Refractive Surgeons (UKISCRS) Cornea & Cataract Day 2026, taking place on 16 March in Edinburgh. The event brings together leading ophthalmic professionals...

Théa Academy Launches 2026 Educational Webinar Programme

26 March 2026 | Company Profiles, Research & Development, Recruitment & Personnel
Théa Academy is pleased to introduce the next phase of its 2026 educational webinar series, offering a varied programme of expert led sessions designed for all eye care professionals. After April’s webinar, Lids, Light & Lifestyle: A Holistic Pathway for...

Treatment for cause of sudden sight loss now available through the NHS in England

24 September 2025 | LHON, NICE, vision Loss, mitochondrial disease, NHS England
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

NICE approves treatment for cause of sudden sight loss

15 October 2025 | genetics, neuro-ophthalmology, drugs, new treatments, mitochondrial
The National Institute for Health and Care Excellence (NICE) has approved a treatment for Leber Hereditary Optic Neuropathy (LHON), called Idebenone (Raxone), in those aged 12 and above who are affected by the condition. LHON is a rare mitochondrial genetic...

World-first platform for transparent, fair and equitable use of AI in healthcare

25 November 2025 | artificial intelligence, diabetes, diagnostics, research
Revolutionary AI platform for detecting diabetic eye disease proven safe for NHS. Researchers have developed the world’s first real-world head-to-head testing platform to determine whether commercial artificial intelligence (AI) algorithms are fit for NHS use to detect disease in a...

A closed angle seldom comes alone

1 June 2017 | | EYE - Glaucoma
Case report An 89-year-old lady with dementia was referred to me out of hours by her GP with a few days history of an angry looking left eye for suspected elevated intraocular pressure (IOP). I discovered that this lady first...

How to get out of chairing Zoom Meetings

1 August 2022 | | EYE - Cataract, EYE - Cornea, EYE - Glaucoma, EYE - Imaging, EYE - Neuro-ophthalmology, EYE - Oculoplastic, EYE - Oncology, EYE - Orbit, EYE - Paediatrics, EYE - Pathology, EYE - Refractive, EYE - Strabismus, EYE - Vitreo-Retinal, EYE - General
One of the biggest changes brought on by far over the past two years is the emergence of Zoom, Teams, or a similar virtual platform for conducting the meetings we all know and love. There are many advantages, and also...

Does beauty truly lie in the eye of the beholder?

1 June 2019 | | EYE - General
Simerdip Kaur takes a look at the latest ophthalmology-related news stories and asks which are based on facts and which are ‘fake news’. Headline: Does beauty truly lie in the eye of the beholder? Scleral whitening, iris colour-changing drops and...

Macula re-attachment following intravitreal ranibizumab in rhegmatogenous retinal detachment

1 February 2015 | | EYE - Vitreo-Retinal, EYE - General
Ranibizumab (Lucentis) is a vascular endothelial growth factor inhibitor (anti-VEGF) used for treatment of choroidal neovascular membrane [1]. We report a case where macula off inferior rhegmatogenous retinal detachment was misdiagnosed as wet age-related macular degeneration (AMD) and three intravitreal...